BUSINESS● LOW2h ago · Oct 20, 2026, 7:33 PM

Protein degrader drug developer Lycia seeks $228M in U.S. IPO

Seeking Alpha Tech · north america

Lycia, a company developing protein degrader drugs, is seeking to raise $228 million through an initial public offering in the U.S. This marks a significant financial step for the biotechnology firm.

Read at Seeking Alpha Tech Ask the Analyst about this

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

See it on the live mapEvents around the world right now

More in Business

BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSEC BUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSEC BUSINESS20m agoEastgroup Properties Q3 2026 Earnings PreviewSeeking Alpha Tech BUSINESS20m agoWaste Connections Q3 2026 Earnings PreviewSeeking Alpha Tech